Updated Jul 16, 2026
WIGGANS THOMAS G has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $100K.
Thomas G. Wiggans is a corporate executive and director known for his involvement in the biotechnology sector, particularly with Jasper Therapeutics, Inc. and Annexon, Inc. He has held various roles in the industry, contributing to the development of innovative therapies.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-22 | JSPR | Jasper Therapeutics, Inc. | P — Open-market purchase | 41.0K | $2.43 | $100K |
Thomas G. Wiggans is a corporate executive and director known for his involvement in the biotechnology sector, particularly with Jasper Therapeutics, Inc. and Annexon, Inc. He has held various roles in the industry, contributing to the development of innovative therapies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WIGGANS THOMAS G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.